These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15627031)

  • 1. Control of viral rebound through therapeutic immunization with DermaVir.
    Lisziewicz J; Trocio J; Xu J; Whitman L; Ryder A; Bakare N; Lewis MG; Wagner W; Pistorio A; Arya S; Lori F
    AIDS; 2005 Jan; 19(1):35-43. PubMed ID: 15627031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
    Boyer JD; Kumar S; Robinson T; Parkinson R; Wu L; Lewis M; Weiner DB
    J Med Primatol; 2006 Aug; 35(4-5):202-9. PubMed ID: 16872283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.
    DiNapoli SR; Ortiz AM; Wu F; Matsuda K; Twigg HL; Hirsch VM; Knox K; Brenchley JM
    JCI Insight; 2017 Feb; 2(4):e91214. PubMed ID: 28239657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DermaVir: a novel topical vaccine for HIV/AIDS.
    Lisziewicz J; Trocio J; Whitman L; Varga G; Xu J; Bakare N; Erbacher P; Fox C; Woodward R; Markham P; Arya S; Behr JP; Lori F
    J Invest Dermatol; 2005 Jan; 124(1):160-9. PubMed ID: 15654970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
    Metzner KJ; Binley JM; Gettie A; Marx P; Nixon DF; Connor RI
    Retrovirology; 2006 Dec; 3():97. PubMed ID: 17184540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
    Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
    Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of SIV rebound through structured treatment interruptions during early infection.
    Lori F; Lewis MG; Xu J; Varga G; Zinn DE; Crabbs C; Wagner W; Greenhouse J; Silvera P; Yalley-Ogunro J; Tinelli C; Lisziewicz J
    Science; 2000 Nov; 290(5496):1591-3. PubMed ID: 11090360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DermaVir, a novel HIV immunisation technology.
    Lori F; Trocio J; Bakare N; Kelly LM; Lisziewicz J
    Vaccine; 2005 Mar; 23(17-18):2030-4. PubMed ID: 15755566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Schmitz JE; Kuroda MJ; Santra S; Sasseville VG; Simon MA; Lifton MA; Racz P; Tenner-Racz K; Dalesandro M; Scallon BJ; Ghrayeb J; Forman MA; Montefiori DC; Rieber EP; Letvin NL; Reimann KA
    Science; 1999 Feb; 283(5403):857-60. PubMed ID: 9933172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
    Binley JM; Clas B; Gettie A; Vesanen M; Montefiori DC; Sawyer L; Booth J; Lewis M; Marx PA; Bonhoeffer S; Moore JP
    Virology; 2000 Apr; 270(1):237-49. PubMed ID: 10772996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.
    Vargas-Inchaustegui DA; Xiao P; Demberg T; Pal R; Robert-Guroff M
    Immunology; 2015 Jun; 145(2):288-99. PubMed ID: 25626488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
    Kumar R; Orsoni S; Norman L; Verma AS; Tirado G; Giavedoni LD; Staprans S; Miller GM; Buch SJ; Kumar A
    Virology; 2006 Oct; 354(1):192-206. PubMed ID: 16876224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
    Cristillo AD; Lisziewicz J; He L; Lori F; Galmin L; Trocio JN; Unangst T; Whitman L; Hudacik L; Bakare N; Whitney S; Restrepo S; Suschak J; Ferrari MG; Chung HK; Kalyanaraman VS; Markham P; Pal R
    Virology; 2007 Sep; 366(1):197-211. PubMed ID: 17499328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.